Recombinant Human Thrombopoietin Completed Phase 3 Trials for Idiopathic Thrombocytopenic Purpura Treatment

IndicationsStatusPurposePhase
CompletedTreatment3
clinicaltrials.gov IdentifierTitleDrugs
NCT02139501An Investigation of rhTPO With Different Frequencies in the Management of ITP